Gavi must reform its operational model to remain fit-for-purpose
Janeen Madan Keller, deputy director of global health policy, at Center for Global Development, explains to Viveka Roychowdhury…
Author
Our aim is to tailor our oncology portfolio to address the most pressing needs in India
Pratima Reddy, Country Speaker for Merck India & MD, Merck Specialties elaborates on the company’s partnerships with national…
CDSCO cracks down on export licenses, antibiotic approvals
Can online courses and training programmes guarantee more effective regulation and better quality medicines?
Aurigene Pharmaceutical Services introduces Aurigene.AI
AI and ML-assisted platform reduced cycle time from chemical design to synthesis and testing by 35 per cent
Pharma gives UCPMP the thumbs up, health activists cry foul
Health activists raise doubts on pharma associations self-monitoring the code
Proposed new drug law may still have flaws
The centre-state power equation works well in theory, as a system of checks and balances. But practice has been anything but…
Why Mankind Pharma’s IPO could be a milestone
While Mankind Pharma’s IPO re-validates the long-term potential of the India Pharma Inc narrative, it won’t take much for the…
There is a high-quality talent pool in the specialist area of pharma engineering design in India
With over 55 per cent of the Dublin-based PM Group's business coming from the pharma sector, Anandhi Sathyamurthy, MD-India, PM…
Immunising India’s pharma supply chain
With China battling another COVID wave, have previous supply shocks helped immunise India's pharma procurement systems?
We will maintain a growth rate in the high teens for both (CDMO and API business) in the next few…
In a recent interaction, Manoj Mehrotra, President Pharmaceuticals, Hikal explains to Viveka Roychowdhury how Hikal's plans to be…